Crispr Infuses First Human in Landmark Gene-Editing Study
A model of human DNA is silhouetted against a window (Photographer: Daniel Acker/Bloomberg News)

Crispr Infuses First Human in Landmark Gene-Editing Study

(Bloomberg) -- Crispr Therapeutics AG  shares surged after the company said it has treated the first human with the same genetic technology that shares its name in an early-stage study.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.